EE137 Comparison of the Cost-Effectiveness of Sequential Treatment with Abaloparatide Followed By Alendronate between US Women and Men at Increased Risk of Fracture.

Saved in:
Bibliographic Details
Title: EE137 Comparison of the Cost-Effectiveness of Sequential Treatment with Abaloparatide Followed By Alendronate between US Women and Men at Increased Risk of Fracture.
Authors: Hiligsmann, M.1 (AUTHOR), Silverman, S.2 (AUTHOR), Singer, A.J.3 (AUTHOR), Pearman, L.4 (AUTHOR), Wang, Y.4 (AUTHOR), Caminis, J.4 (AUTHOR), Reginster, J.Y.5 (AUTHOR)
Source: Value in Health. 2023 Supplement, Vol. 26 Issue 6, pS84-S84. 1p.
Database: Academic Search Ultimate
Be the first to leave a comment!
You must be logged in first